StockData
MariMed Inc. logo

MariMed Inc. (MRMD) income statement

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
35.4%
Operating margin
-1.7%
Net margin
-9.3%
Return on equity, FY2025
–

Financial strength

Current ratio
0.90
Debt to equity
–
Debt to assets
–
Cash to current liabilities
15.2%

Valuation

P/E ratio
–
Price to sales
0.14
Price to book
–
Dividend yield
–

See a number that looks wrong?